PARIS & CAMBERLEY, England--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the expansion of its VersaLab portfolio with the launch of VersaLab Portable to provide an additional level of support in near-patient testing environments. VersaLab was launched in December 2020 to support private sector testing of infectious diseases, initially focused on COVID-19. Novacyt added to the VersaLab portfolio